Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Megapolitan Developments Tbk. (EMDE) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Megapolitan Developments Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Megapolitan Developments Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Megapolitan Developments Tbk. trades at Rp77 (market cap 261.3B, 5.78M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.4× Megapolitan Developments Tbk.'s market cap, and Megapolitan Developments Tbk. is more actively traded (5.78M versus 843K). Which is the better fit depends on your goals.

EMDELABS
Market Cap
261.3B635.95B
Volume
5.78M843K
Lot
57.76K8.43K
Turnover
444.84M137.6M
Average Price
77.02163.22
Value
444.84M137.6M
Indicative Equilibrium Price
77165
Indicative Equilibrium Volume
884246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EMDE
View details
LABS
View details

About Megapolitan Developments Tbk.

PT Megapolitan Developments (formerly Megapolitan Developments Corporation) (the Company) was established based on Notary Deed No. 24 dated September 10, 1976 by Soeleman Ardjasasmita, S.H., Notary in Jakarta.

Read more on EMDE

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS